Adaptimmune Therapeutics (ADAP) Insider Trading & Ownership $0.60 -0.01 (-0.83%) (As of 12:21 PM ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Adaptimmune Therapeutics (NASDAQ:ADAP) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage12.44%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)4Amount OfInsider Selling(Last 12 Months)$53,507.07 Get ADAP Insider Trade Alerts Want to know when executives and insiders are buying or selling Adaptimmune Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address ADAP Insider Buying and Selling by Quarter Ad Porter & CompanyGates and Bezos chuck millions at controversial AI techIf you’re worried you’re late for the AI boom, read this. The AI boom is just getting started. While everyone is rushing to buy the latest artificial intelligence start-up or pile even more money into Nvidia, I’m recommending that you do the opposite.To get all the details, go here now. Adaptimmune Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails6/18/2024Cintia PiccinaInsiderSell24,531$0.93$22,813.83 1/16/2024Adrian RawcliffeCEOSell9,304$0.79$7,350.16 1/16/2024Elliot NorryInsiderSell2,287$0.79$1,806.73 1/16/2024William C Bertrand JrCOOSell4,681$0.79$3,697.99 1/12/2024William C Bertrand JrCOOSell5,220$0.85$4,437.00 1/11/2024Adrian RawcliffeCEOSell11,945$0.84$10,033.80 1/11/2024Elliot NorryInsiderSell4,009$0.84$3,367.56 (Data available from 1/1/2013 forward) ADAP Insider Trading Activity - Frequently Asked Questions Who is on Adaptimmune Therapeutics's Insider Roster? The list of insiders at Adaptimmune Therapeutics includes Adrian Rawcliffe, Cintia Piccina, Elliot Norry, Garry E Menzel, Gavin Wood, John Lunger, and William C Bertrand Jr. Learn more on insiders at ADAP. What percentage of Adaptimmune Therapeutics stock is owned by insiders? 12.44% of Adaptimmune Therapeutics stock is owned by insiders. Learn more on ADAP's insider holdings. Which Adaptimmune Therapeutics insiders have been selling company stock? The following insiders have sold ADAP shares in the last 24 months: Adrian Rawcliffe ($80,768.78), Cintia Piccina ($45,048.13), Elliot Norry ($5,174.29), Garry E Menzel ($43,408.82), John Lunger ($19,660.01), and William C Bertrand Jr ($22,695.78). How much insider selling is happening at Adaptimmune Therapeutics? Insiders have sold a total of 181,234 Adaptimmune Therapeutics shares in the last 24 months for a total of $216,755.81 sold. Adaptimmune Therapeutics Key ExecutivesMr. Adrian G. Rawcliffe (Age 52)CEO, Principal Accounting Officer & Director Compensation: $1.06MDr. Helen Katrina Tayton-Martin MBA (Age 57)Ph.D., Co-Founder & Chief Business & Strategy Officer Compensation: $677.4kMr. Gavin Hilary James Wood ACA (Age 54)BA (Hons), Chief Financial Officer Compensation: $666.34kDr. Elliot Norry B.A. (Age 60)M.D., Chief Medical Officer Compensation: $676.19kMs. Joanna Brewer Ph.D. (Age 48)Chief Scientific Officer Dr. Juli P. Miller Ph.D.VP of Corporate Affairs & Investor RelationsMs. Kerry SharpSenior VP & General CouncilDana LynchSenior Director of Corporate CommunicationsMr. John Lunger (Age 54)Chief Patient Supply Officer Compensation: $645.91kMr. Dennis WilliamsSenior Vice President of Late Stage Development More Insider Trading Tools from MarketBeat Related Companies ORIC Pharmaceuticals Insider Transactions Terns Pharmaceuticals Insider Transactions Tourmaline Bio Insider Transactions Phathom Pharmaceuticals Insider Transactions ProKidney Insider Transactions Astria Therapeutics Insider Transactions Ginkgo Bioworks Insider Transactions Annexon Insider Transactions Humacyte Insider Transactions AnaptysBio Insider Transactions Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles AppLovin Insiders Sell Shares: Stock Price Indicated Higher Are 2024’s Top Insider Buys a Good Bet for 2025? Bargains Galore? 3 Stocks With Insider Buying in the MillionsInsiders Keep Buying These Stocks: 2 to Buy, 1 to AvoidZeta Global Holdings Insiders Buy Stock After Short-Report This page (NASDAQ:ADAP) was last updated on 12/20/2024 by MarketBeat.com Staff From Our PartnersHealthcare Takes A Big Step Forward With The Help of A.I.To date, we've seen baseline AI models lay the groundwork. Tools like ChatGPT are useful, but they are still s...Wall Street Star | SponsoredDo this Before Elon’s Reveal on January 22ndElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | SponsoredBuffett's Oil Bet + This 22% Dividend PlayWarren Buffett has been quietly amassing a massive position in oil stocks. But while Buffett's picks (Occid...Investors Alley | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored“Energy’s holy grail” just discoveredIt’s 17,000 times more powerful than gas… 2.75 million times more powerful than coal… and a staggering… 3 mill...Banyan Hill Publishing | SponsoredSeeing is believing… Today, I want to share all the details with you… and show you how to leverage this incredible wealth-building ...Porter & Company | SponsoredBitcoin is going to $100,000 … before Inauguration DayMark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredWe recommended Palantir in 2021, now we’re recommending this...My research indicates there is only one investment that can meet AI's unprecedented demand for energy.Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Adaptimmune Therapeutics plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Adaptimmune Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ADAP Stock Alerts